FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Did Trump Ban Woman and Disabled at FDA?

[ Price : $8.95]

FDA staff tell Reuters a potentially bogus list of words that cant be used in external communications under a Trump Executive Orde...

LDT Court Ruling As Soon As Possible, Judge Says

[ Price : $8.95]

The Texas federal judge hearing the consolidated cases against FDA over its final rule on laboratory-developed tests promises a ru...

Bill for Canadian Drug Imports Reintroduced

[ Price : $8.95]

Sens. Charles Grassley and Amy Klobuchar reintroduce legislation to provide for safe importation of drugs from Canada.

FDA Clears Ezra Flash AI

[ Price : $8.95]

FDA clears an Ezra 510(k) for its Ezra Flash AI model for MRI imaging.

PolarityBio Gets Breakthrough Status for SkinTE

[ Price : $8.95]

FDA grants PolarityBio a breakthrough therapy designation for SkinTE for treating Wagner Grade 1 diabetic foot ulcers.

FDA Refusal to File Wakix sNDA

[ Price : $8.95]

FDA refuses to file a Harmony Biosciences Wakix sNDA to treat excessive daytime sleepiness due to idiopathic hypersomnia.

AGs Seek FDA Actions on Counterfeit GLP-1 Drugs

[ Price : $8.95]

A bipartisan coalition of 37 state Attorneys General call on FDA to take enforcement actions against online sellers of counterfeit...

2024 Device Recalls Up, Drug Recalls Down: Sedgwick

[ Price : $8.95]

The Sedgwick full-year recall report for 2024 shows medical device recalls increasing and drug recalls decreasing.

Becton Dickinson Recalls ChloraPrep Lot

[ Price : $8.95]

Becton Dickinson recalls one lot of ChloraPrep clear 1 mL applicators due to fungal contamination concerns.

Disappointing Data on Supernus Depression Drug

[ Price : $8.95]

Supernus Pharmaceuticals says its Phase 2b study of SPN-820 in adults with treatment-resistant depression did not demonstrate a st...